Alliance Cancer Care Joins Clearview Cancer Institute As its Radiation Oncology Division Treating Patients in North Alabama

UTulsa doctoral student develops rehab robotics for cerebral palsy patients, others

Iterion Therapeutics Announces Oral Presentation of Phase 1/2 Tegavivint Data in Advanced Hepatocellular Carcinoma at the 2026 ASCO Annual Meeting

Accord Healthcare US Relaunches Tadalafil Tablets, Broadening Availability of Approved Dosage Strengths

Kedrion Highlights Commitment to Rare and Ultra‑Rare Diseases on Plasminogen Deficiency Awareness Day

PRIVACY ALERT: Sandhills Medical Foundation, Inc. Under Investigation for Data Breach of Over 169,000 Patient Records

Par Health Names Norv McAndrew as EVP, Chief Legal Officer and Corporate Secretary

Trinity Offers InsightsEDGE Free Trial at PMSA 2026 in New Orleans

InFocus Clinical Research names Elizabeth Nanouris Vice President of Business Operations

Biotheryx to Present Results from its Phase 1A Dose Escalation Study of BTX-9341 for the Treatment of HR+/HER2- Breast Cancer at the 2026 European Society for Medical Oncology Breast Cancer Annual Congress

DIAMONDROCK HOSPITALITY COMPANY ANNOUNCES SALE OF THE COURTYARD BY MARRIOTT NEW YORK MANHATTAN/FIFTH AVENUE

Vohra Wound Physicians Named to Newsweek's America's Greatest Midsize Workplaces in Health Care 2026

Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'2118, a Corticotropin-Releasing Factor Type 2 Receptor Agonist

Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026

GRIN Therapeutics' Pivotal Phase 3 Beeline Study Initiated in Europe

Weight-Loss Drugs' Gains Lift Pharma R&D Returns, but 'Bubble' Risk Grows

Ascidian Completes Dose Escalation Portion of Phase 1/2 STELLAR Trial of ACDN-01 for Stargardt Disease and Announces Expanded Clinical Study Plans

EIR Healthcare Partners with MillerKnoll to Deliver Factory-Integrated Interior Solutions, Advancing a New Model for Healthcare Construction

ASHA-YouGov National Caregiver Poll: Communication Breakdowns Are Raising Safety Concerns

Olympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio

New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer

Results of the Randomized Controlled Trial of At-Home Subcutaneous Diuretic Therapy for Heart-Failure Associated Edema to Be Presented at Heart Failure 2026

Karen Eckert Honored for Decades of Leadership and Named NCPDP's 2026 TIME Award Recipient

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

Vireo Growth Inc. Announces Effectiveness of Management Services Agreement with PharmaCann Inc.

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones

Laplace Announces FDA IDE Approval of TRIUMPH Pivotal Trial of Its Transcatheter Tricuspid Valve Replacement System

AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg